Find Research
Our World View
Industry Perspectives
Research Program
Parallax View Magazine
> stay tuned
View our collections of research around key subject areas:
>
>
>
>
ERP
>
>
>
>
>
>
>
SRM
>
>
WMS
 
 
Event
CBI Supply Chain Optimization Congress
Mitigate Costs through Streamlined Processes, Strategic Sourcing and Ensuring Supply Chain Integrity


Full Article Below -
CBI | Powering Thought Leadership, Partnerships and Innovation in Life Sciences
Skip navigation

CBI

Pharma Forum 2019 promo banner
20th Annual Patient Assistance and Access Programs – PAP 2019 promo banner
Hub and SPP Model Optimization promo banner
Speaker Programs 2019 promo banner
Clinical Data Disclosure and Transparency promo banner

Powering Thought Leadership, Partnerships and Innovation in Health and Life Sciences

Pharma Forum 2019 promo banner
20th Annual Patient Assistance and Access Programs – PAP 2019 promo banner
Hub and SPP Model Optimization promo banner
Speaker Programs 2019 promo banner
Clinical Data Disclosure and Transparency promo banner

It was great to benchmark with other companies as well as walk away with tangible and practical ideas...

Pharmacovigilence Manager, Fleet Laboratories

Only CBI delivers consistent high quality...

Chairman, Harvest Moon Pharmaceuticals

Class act.

Director, Specialty Pharmacy Programs, BlueCross BlueShield South Carolina

CBI continues to deliver ‘Collaboration’ and ‘Best-In-Class Interaction’ with our industry's finest.

Director, Head of Technical Accounting, Sanofi

Latest from the CBI Blog

Q&A with Edward Cox, CEO Dthera™ Sciences Evanna Payen   (Nov 26, 2018)

Edward Cox is CEO of Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, based in San Diego, CA. This summer they gained FDA breakthrough designation for their development-stage product, DTHR-ALZ for the symptoms of Alzheimer’s. We sat down with Ed to find out what this means and where he thinks things are headed for the rapidly advancing digital therapeutic products sector.

Q: What does receiving FDA breakthrough status mean for not just your company but the Digital Therapeutic sector as a whole?

[Read More]

See all CBI blog posts >>

About CBI

CBI Events, a division of UBM Americas
Powering Thought Leadership, Partnerships and Innovation in Health and Life Sciences

CBI is the health and life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries. CBI’s proprietary and intensive market research and product feasibility testing methodology has helped CBI deliver timely and first to market content driven conferences. These include annual flag ship events such as Pharma Forum, PCC (Pharmaceutical Compliance Congress), PAP (Patient Assistance & Access Programs), Life Sciences Accounting & Reporting Congress, and Medicaid and Government Pricing Congress.

Benefiting over 13,000 executives annually, CBI has provided the life sciences industry with leading-edge, actionable information on the most compelling industry trends for more than two decades. CBI’s conferences, forums, summits, workshops and other events also serve to connect executives and decision-makers with technology, regulatory and consulting solutions from Fortune 500 companies, and the most cutting-edge solution providers. [Meet the Team]

70 Blanchard Road
Burlington, MA 01803
Toll Free: (800) 817-8601
Phone: (339) 298-2100




MarketViz powered.